Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
25 studies found for:    therapeutic vaccine | Open Studies | HIV
Show Display Options
Rank Status Study
1 Recruiting Safety and Immunogenicity of HIVAX in HIV-1 Infected Subjects
Condition: HIV Infections
Interventions: Biological: HIVAX;   Biological: saline solution
2 Recruiting iHIVARNA Clinical Trial in HIV Infected Individuals
Condition: HIV Infections
Interventions: Biological: iHIVARNA-01;   Biological: TriMix;   Biological: Placebo
3 Recruiting Clinical Trial of Recombinant Adenovirus Type 5 AIDS Vaccine
Condition: Acquired Immunodeficiency Syndrome
Interventions: Biological: Ad5-gag;   Biological: Placebo
4 Not yet recruiting Maraviroc on HIV-1 Infected Subjects Who Require Allogeneic Hematopoietic Cell Transplant
Condition: HIV-1-infection
Interventions: Other: For Step 2: Structured treatment interruption;   Procedure: Peripheral blood draw
5 Recruiting Therapeutic HPV-16 Vaccination for the Treatment of Anal Dysplasia
Conditions: Anal Intraepithelial Neoplasia;   HIV
Intervention: Drug: HPV-16 vaccine
6 Not yet recruiting An HIV Vaccine Trial in Individuals Who Started ART During Primary or Chronic Infection
Condition: Hiv
Interventions: Biological: GTU-MultiHIV B-clade vaccine;   Biological: MVA HIV-B HIV vaccine;   Biological: Placebo 1: Sodium Chloride;   Biological: Placebo 2:S08 buffer
7 Not yet recruiting REMUNE HIV/AIDS Vaccine Phase II Pediatric Safety & Efficacy Clinical Study
Condition: HIV/AIDS
Intervention: Biological: REMUNE
8 Recruiting HPV (Human Papilloma Virus) Vaccination After Treatment of Anal Intraepithelial Neoplasia (AIN)
Conditions: AIN;   HIV
Interventions: Biological: Gardasil;   Drug: Placebo
9 Not yet recruiting REMUNE + AMPLIVAX IR103 HIV/AIDS Phase III Safety & Efficacy Study
Condition: HIV
Intervention: Biological: IR103
10 Not yet recruiting Immunogenicity and Safety of the Yellow Fever Vaccine in HIV Infected Individuals
Condition: HIV Infections
Intervention: Biological: Yellow Fever vaccination (17 DD Biomanguinhos)
11 Recruiting Pivotal Phase 2b/3 ALVAC/Bivalent gp120/MF59 HIV Vaccine Prevention Safety and Efficacy Study in South Africa
Condition: HIV Infections
Interventions: Biological: ALVAC-HIV (vCP2438);   Biological: Bivalent Subtype C gp120/MF59;   Biological: Placebo
12 Recruiting Improving Identification of Social Harm Among Substance Abusers in HIV Trials
Conditions: Social Harms in Substance Users in HIV Trials;   Audio Computer Assisted Self-administered Questionnaire
Intervention:
13 Recruiting Mechanisms of Impaired HIV-associated B Cell and Pneumococcal Vaccine Responses
Conditions: HIV;   Pneumococcal Infections;   Pneumococcal Vaccines
Interventions: Biological: PCV-13;   Biological: PPSV-23
14 Recruiting Characterization of Acute and Recent HIV-1 Infections in Zurich: a Long-term Observational Study
Condition: HIV Infections
Interventions: Drug: Dolutegravir;   Drug: Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamid Fumarate;   Drug: Raltegravir;   Drug: Darunavir;   Drug: Ritonavir;   Drug: Rilpivirine;   Drug: Lamivudine;   Drug: tenofovir;   Drug: Emtricitabine;   Drug: Abacavir
15 Recruiting Pilot Trial of the Effect of Vorinostat and AGS-004 on Persistent HIV-1 Infection
Condition: HIV-1 Infection
Interventions: Drug: Vorinostat;   Biological: AGS-004
16 Recruiting Integrated Stepped Care for Unhealthy Alcohol Use in HIV
Conditions: Liver Diseases, Alcoholic;   Alcoholism;   HIV;   Hepatitis C
Interventions: Other: Integrated Stepped Care (ISC);   Other: Treatment as Usual
17 Recruiting Prevention of HIV in "Île-de-France"
Condition: HIV Infections
Intervention: Drug: PrEP with Truvada®
18 Recruiting Evaluating the Safety, Tolerability, and Pharmacokinetics of Bedaquiline and Delamanid, Alone and in Combination, For Drug-Resistant Pulmonary Tuberculosis
Conditions: Tuberculosis;   HIV Infections
Interventions: Drug: Bedaquiline;   Drug: Delamanid;   Drug: Dolutegravir
19 Recruiting Safety and Immunogenicity of a Vaccine Dendritic Cell-based Pulsed With Autologous Heat-inactivated in HIV-1 Infected Patients
Condition: HIV Infection
Interventions: Biological: DCV3;   Biological: DCV3 with PEG-INF;   Biological: Placebo;   Biological: Placebo with PEG-INF
20 Recruiting Trial to Evaluate the Interest of a Reductive Anti Retroviral Strategy Using Dual Therapy Inspite of Triple Therapy
Condition: HIV
Interventions: Drug: triple therapy;   Drug: dual therapy

   Previous Page Studies Shown (1-20) Next Page (21-25) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.